NRX Pharmaceuticals Inc Financial Flexibility Index
NRX Pharmaceuticals Inc financial flexibility index. NRX Pharmaceuticals Inc (NRXP) has a Financial Flexibility Index of -0.07x as of September 2025. Free cash flow of $-2.89 Million (operating CF $-2.89 Million minus capex $0.00) represents 0% of total liabilities ($40.75 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of NRX Pharmaceuticals Inc (2017–2024)
Financial flexibility index of NRX Pharmaceuticals Inc from 2017 to 2024. Historical Financial Flexibility Index trend for NRX Pharmaceuticals Inc across 8 annual periods. Check NRX Pharmaceuticals Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
NRX Pharmaceuticals Inc Financial Flexibility Index by Year (2017–2024)
NRX Pharmaceuticals Inc financial flexibility index by year from 2017 to 2024. Year-by-year free cash flow to debt coverage for NRX Pharmaceuticals Inc. For the full cash flow conversion analysis, see NRXP cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.40x | $-10.64 Million | $-10.64 Million | $26.87 Million | ▲ +65.2% |
| 2023 | -1.14x | $-21.65 Million | $-21.66 Million | $19.05 Million | ▲ +47.4% |
| 2022 | -2.16x | $-39.74 Million | $-39.76 Million | $18.41 Million | ▲ +31.7% |
| 2021 | -3.16x | $-37.70 Million | $-37.70 Million | $11.92 Million | ▼ -6426.1% |
| 2020 | -0.05x | $-2.26 Million | $-2.27 Million | $46.71 Million | ▲ +84.3% |
| 2019 | -0.31x | $-792.73K | $-792.73K | $2.57 Million | ▲ +18.2% |
| 2018 | -0.38x | $-473.19K | $-473.19K | $1.26 Million | ▲ +74.2% |
| 2017 | -1.46x | $-135.81K | $-135.81K | $93.17K | — |